REFERENCES
  1. Caselli D, Cesaro S, Fagioli F, Carraro F, Ziino O, Zanazzo G, Meazza C, Colombini A, Castagnola E; Infectious Diseases Study Group of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Incidence of colonization and bloodstream infection with carbapenem-resistant Enterobacteriaceae in children receiving antineoplastic chemotherapy in Italy. Infect Dis 2016;48:152-5.
  2. Arendrup MC, Hope W, Howard SJ. EUCAST Definitive Document E.Def 9.2 Method for the Determination of Broth Dilution Minimum Inhibitory Concentrations of Antifungal Agents for Conidia Forming Moulds; EUCAST: Basel, Switzerland, 2014.
  3. Clinical Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard, 2nd ed.; CLSI document M38-A2; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2008.
  4. Martelius T, Jalava J, Kärki T, Möttönen T, Ollgren J, Lyytikäinen O; Hospital Infection Surveillance team. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality. Infect Dis 2016;48:229-34.
  5. Marín M, Gudiol C, Garcia-Vidal C, Ardanuy C, Carratalà J. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center. Medicine (Baltimore). 2014 May;93(3):143-9.
  6. RED BOOK (XXXI 2018-2021). American Academy of Pediatrics.ISBN : 978-88-3379-098-5